Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA · NASDAQ · Financial Services / Shell Companies

10.90USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close10.90

Open10.90

Day Range10.90 – 10.90

52-Week Range10.26 – 10.86

Volume0

Market Cap263.16M

P/E (TTM)60.22

Forward P/E0.00

EPS0.18

Dividend Yield0.00%

50-Day Avg10.75

200-Day Avg10.57

About

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Company Details

SectorFinancial Services
IndustryShell Companies
CEOMr. Roger Bendelac
Employees0
Headquarters420 Lexington Avenue, New York, NY, United States, 10170, USA
Websitehttps://dmaacorp.com

Leadership

Mr. Roger BendelacChief Executive Officer · b. 1957

Financials

Income Statement

Currency: USD	2024-12-31	2025-12-31
Total Revenue	-	0
Operating Income	-479	-2.82M
EBITDA	-279.85K	-2.82M
Net Income	-479	5.94M

Balance Sheet

Currency: USD	2024-12-31	2025-12-31
Total Assets	550.82	239.92M
Total Liabilities	795.67	7.28M
Total Equity	-244	232.64M
Cash	1.35K	6.14K
Total Debt	662.32	-
Net Debt	660.97	-6.14K

Cash Flow

Currency: USD	2024-12-31	2025-12-31
Operating Cash Flow	-172.26K	-539.19K
Investing Cash Flow	-	-231.15M
Financing Cash Flow	173.62K	231.69M
Capital Expenditure	5	0
Free Cash Flow	-295	-539.19K
FCF to OCF	0.17%	100.00%

Earnings

Report Date	Mar 31, 2025	May 20, 2025	Aug 14, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	0.00	-	-	-	-	-	-
EPS Actual	-0.03	0.05	0.07	0.07	0.01	0.06	0.06
Surprise	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap263.16M

Enterprise Value264.33M

Trailing P/E60.22

Forward P/E0.00

Price / Sales0.00

Price / Book1.91

EPS0.18

Book Value-0.305

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets-1.46%

Shares Outstanding24.28M

Shares Float19.79M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 52.34%
Insiders: 23.57%
Retail / Other: 24.09%

Top Institutional Holders

Karpus Management Inc
2.53M10.42%
First Trust Capital Management L.P.
2.24M9.24%
Mizuho Securities USA Inc
2.00M8.24%
Westchester Capital Management LLC
1.67M6.87%
Polar Asset Management Partners
1.60M6.59%
Wolverine Asset Management LLC
1.55M6.40%
Highbridge Capital Management, LLC
1.32M5.45%
Glazer Capital, LLC
999.90K4.12%
Heights Capital Management Inc
650.00K2.68%
Shaolin Capital Management LLC
550.00K2.27%
Radcliffe Group Inc
546.81K2.25%
LMR Partners LLP
500.00K2.06%
Whitebox Advisors, LLC
400.00K1.65%
Meteora Capital, LLC
380.30K1.57%
Cnh Partners, LLC
357.58K1.47%
Clear Street Group Inc
354.05K1.46%
Aristeia Capital, LLC
350.00K1.44%
Quarry LP
266.55K1.10%

Top Fund Holders

First Trust Merger Arbitrage Cl I
675.37K2.78%
The Merger Fund A
564.80K2.33%